Long lags in the testing of street drugs and the heightened risk of overdoses and deaths among users exposed to tainted drugs amid North America’s unprecedented opioid crisis are the target of a groundbreaking partnership between researchers at Carleton University and the University of Ottawa that is piloting the use of a portable mass spectrometer to test drug samples at an Ottawa supervised injection site.
Tattoo artist grateful to be off blood thinners thanks to made-in-Ottawa rule.
“I could see a significant change in my personality that just wasn’t me.”
OTTAWA, May 15, 2019 – Research Canada and the Parliamentary Health Research Caucus are hosting an invitation-only reception to introduce Parliamentarians to thirteen of Canada’s...
New national poll views health and medical research as having greater impact over the past decade FOR IMMEDIATE RELEASE OTTAWA,...
OTTAWA, April 10, 2019 — More than 11 Canadians are dying every day on average because of opioids, according to new data...
OTTAWA, April 3, 2019 – Senator Judith Seidman, Senate Representative of the Parliamentary Health Research Caucus, will co-host with Research...
FOR IMMEDIATE RELEASE OTTAWA, March 20, 2019 – Budget 2019 strengthens the federal government’s commitment to the research environment and a...
